Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Newborn Phosphocalcic Metabolism After Intravenous Iron Administration During Pregnancy

NCT06108258 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.

NCT NCT06108258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06108258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Newborn Phosphocalcic Metabolism After Intravenous Iron Administration During Pregnancy
Lead sponsor
University Hospital, Geneva
Phase
Observational
Overall status
Completed
Start date
September 23, 2022
Completion date
March 3, 2023
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iron induced hypophosphatemia